{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:47:58Z","timestamp":1791287278211,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,15]]},"DOI":"10.1097\/qai.0b013e31816856db","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T03:01:50Z","timestamp":1205118110000},"page":"585-591","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania"],"prefix":"10.1097","volume":"47","author":[{"given":"Susan C","family":"Morpeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M","family":"Thielman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib O","family":"Ramadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R","family":"Kisenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey J","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Barth","family":"Reller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafrosa K","family":"Itemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel E","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Crump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210131","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","article-title":"Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote dIvoire: a randomised trial.","volume":"353","author":"Anglaret","year":"1999","journal-title":"Lancet"},{"key":"R2-9-20210131","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","article-title":"Cotrimoxazole prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.","volume":"364","author":"Chintu","year":"2004","journal-title":"Lancet"},{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.aids.0000174449.32756.c7","article-title":"Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members.","volume":"19","author":"Mermin","year":"2005","journal-title":"AIDS"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(99)03465-0","article-title":"Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote dIvoire: a randomised controlled trial.","volume":"353","author":"Wiktor","year":"1999","journal-title":"Lancet"},{"key":"R5-9-20210131","first-page":"30","article-title":"Provisional WHO\/UNAIDS recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV\/AIDS in Africa.","volume":"1","author":"World Health Organization","year":"2001","journal-title":"Afr Health Sci"},{"key":"R6-9-20210131","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.35.7.1915-1915.1997","article-title":"Susceptibilities to cotrimoxazole of pathogens isolated from blood and stool specimens in Abidjan, Ivory Coast, 1994 to 1996.","volume":"35","author":"Anglaret","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R7-9-20210131","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3201\/eid0801.010018","article-title":"Antimicrobial sensitivity in Enterobacteria from AIDS patients, Zambia.","volume":"8","author":"Mwansa","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"R8-9-20210131","first-page":"626","article-title":"A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV.","volume":"39","author":"van Oosterhout","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-9-20210131","first-page":"735","article-title":"Integrated management of the sick child.","volume":"73","year":"1995","journal-title":"Bull World Health Organ"},{"key":"R11-9-20210131","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1089\/aid.2007.0053","article-title":"Predicting CD4 lymphocyte count 200 cells\/mm3 in an HIV-1-infected African population.","volume":"23","author":"Morpeth","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R12-9-20210131","first-page":"24","article-title":"Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings.","volume":"8","author":"Forna","year":"2006","journal-title":"AIDS Rev"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1086\/505866","article-title":"Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003.","volume":"43","author":"Brooks","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R17-9-20210131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0035-9203(02)90306-8","article-title":"Changes in Escherichia coli resistance to co-trimoxazole in tuberculosis patients and in relation to co-trimoxazole prophylaxis in Thyolo, Malawi.","volume":"96","author":"Zachariah","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R18-9-20210131","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(01)06227-4","article-title":"Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa.","volume":"358","author":"Anglaret","year":"2001","journal-title":"Lancet"},{"key":"R19-9-20210131","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","article-title":"Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-count, and viral load in HIV infection in rural Uganda.","volume":"364","author":"Mermin","year":"2004","journal-title":"Lancet"},{"key":"R20-9-20210131","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00002030-200305020-00015","article-title":"Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi.","volume":"17","author":"Zachariah","year":"2003","journal-title":"AIDS"},{"key":"R21-9-20210131","first-page":"354","article-title":"Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.","volume":"82","author":"Mwaungulu","year":"2004","journal-title":"Bull World Health Organ"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/107662904323047763","article-title":"Integron-associated antibiotic resistance in enteroaggregative and enteroinvasive Escherichia coli.","volume":"10","author":"Gassama","year":"2004","journal-title":"Microb Drug Resist"},{"key":"R23-9-20210131","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1128\/JCM.37.10.3113-3117.1999","article-title":"Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania.","volume":"37","author":"Navia","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R24-9-20210131","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/jac\/dkl020","article-title":"The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada.","volume":"57","author":"Blahna","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R25-9-20210131","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/317450","article-title":"Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.","volume":"31","author":"Frenck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R26-9-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-126-9-199705010-00004","article-title":"Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin.","volume":"126","author":"Khan","year":"1997","journal-title":"Ann Intern Med"},{"key":"R27-9-20210131","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-107-4-599_2","article-title":"Cutaneous reactions to trimethoprim-sulfamethoxazole in African patients with acquired immunodeficiency syndrome.","volume":"107","author":"Colebunders","year":"1987","journal-title":"Ann Intern Med"},{"key":"R28-9-20210131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00126334-200102010-00004","article-title":"Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal.","volume":"26","author":"Maynart","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-9-20210131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.inf.0000164707.13624.a7","article-title":"Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.","volume":"24","author":"Jain","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R30-9-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/JB.63.3.399-406.1952","article-title":"Replica plating and indirect selection of bacterial mutants.","volume":"63","author":"Lederberg","year":"1952","journal-title":"J Bacteriol"},{"key":"R31-9-20210131","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1086\/323647","article-title":"Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu.","volume":"184","author":"Walson","year":"2001","journal-title":"J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e31816856db","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:52:23Z","timestamp":1786035143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200804150-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31816856db","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}